Mr. Maurice Mourton
Chairman of the Board |
Mr. Noel Hall
President
Aspreva Pharmaceuticals |
Dr. Lap-Chee Tsui
Associate Scientific Director
Canadian Genetic Diseases Network |
Rt. Hon. Don Mazankowski
Past Chair |
Dr. Michael Hayden
Scientific Director
| Ms. Diane Allan
Networks of Centres of Excellence Program |
Mr. Rob Abbott
President
Abbott Strategies |
Dr. Emőke J.E. Szathmáry
President and Vice-Chancellor
University of Manitoba |
Dr. Martha Piper
President
University of British Columbia |
Mr. David Arkowitz
Controller
Merck & Co. |
Dr. Ron Woznow
Chief Executive Officer
Canadian Genetic Diseases Network |
Mr. Dan Goodleaf
Chief Federal Negotiator & Executive Director
Federal Treaty Negotiation Office |
Mr. Jean-Michel Halfon
President & CEO Officer
Pfizer Canada Inc. |
Mr. Louis Lacasse
President
GeneChem Technologies
Venture Fund Laval |
Dr. Allan Warrack
Professor Emeritus of Business
University of Alberta |
